Skip to main content
⚡ Same-Day Shipping·Order by 3 PM ET, It Ships Today🇺🇸 100% Domestic·Synthesized & Shipped in the USABuy 2+ Save 10%·Buy 3+ Save 15%·Buy 5+ Save 20%Free US Shipping on Crypto, Zelle, Cash App & Venmo OrdersFastest Dispatch in Research Peptides·Same-Day TrackingThird-Party Tested·COAs Available on RequestResearch Grade·≥ 99% Purity Standard⚡ Same-Day Shipping·Order by 3 PM ET, It Ships Today🇺🇸 100% Domestic·Synthesized & Shipped in the USABuy 2+ Save 10%·Buy 3+ Save 15%·Buy 5+ Save 20%Free US Shipping on Crypto, Zelle, Cash App & Venmo OrdersFastest Dispatch in Research Peptides·Same-Day TrackingThird-Party Tested·COAs Available on RequestResearch Grade·≥ 99% Purity Standard
Same-Day Shipping · Order by 3 PM ET
Third-Party Lab Tested
≥99% Purity Guaranteed
Free US Shipping + BAC Water
Recovery Research · 6/26/2026 · 1 min read

ARA-290 Complete Research Guide 2026

ARA-290 is an 11-amino-acid peptide derived from erythropoietin's three-dimensional structure, designed to activate the innate repair receptor rather than the erythropoietin receptor — separating the tissue-protective and neuroprotective EPO effects from its red blood cell-stimulating activity.

By Owen
ShareX / TwitterReddit
For research and laboratory use only. Not for human consumption, diagnosis, or treatment.

Erythropoietin (EPO) has long been studied for effects beyond red blood cell production — tissue protection, neuroprotection, and metabolic effects documented across multiple research contexts. ARA-290 represents an attempt to isolate these non-hematopoietic effects by targeting the innate repair receptor (IRR) specifically, leaving the classical erythropoietin receptor activity behind.

Innate Repair Receptor Mechanism

The innate repair receptor is a heteromeric complex distinct from the classical EPO receptor — believed to mediate EPO's tissue-protective effects without the erythropoietic stimulation. ARA-290's peptide structure was derived from the region of EPO's three-dimensional conformation that engages this complex, providing a research tool for studying IRR-specific biology without the confounding variable of red blood cell production that full EPO administration introduces.

Neuropathic Pain Research

ARA-290's most extensively published research application is neuropathic pain — specifically small fiber neuropathy research where the compound has shown documented effects in reducing pain scores and improving corneal nerve fiber density in clinical studies. This positions ARA-290 in a research category adjacent to recovery peptides like BPC-157 but through a completely distinct mechanistic approach focused on nerve tissue specifically.

Metabolic Research Applications

Beyond neuropathy, the IRR pathway has been studied in metabolic contexts — including insulin sensitivity and pancreatic beta cell protection research — connecting ARA-290 to broader metabolic biology in ways that distinguish it from both the GLP-class compounds and the recovery peptide category.

Related Research Where to Buy ARA-290 USA 2026 BPC-157 Mechanism Deep Dive Best Peptides for Recovery Research 2026

Research Use Only. DisclaimerFor laboratory and research use only. Not for human consumption. This content is educational and does not constitute medical advice.

Running the numbers for a protocol? Use the research calculators to convert mg, mL, and syringe units.

For research and laboratory use only.
Related Research Articles
Recovery Research

TB-500 Expanded Research Guide 2026

TB-500's G-actin sequestration mechanism is deceptively simple — by binding monomeric actin and redirecting the cell's cytoskeletal dynamics, it promotes cell migration in ways that have proven relevant across tissue repair, cardiac, and neurological research contexts far beyond its original wound healing focus.

Recovery Research

GHK-Cu vs BPC-157 Research Comparison 2026

GHK-Cu and BPC-157 are frequently compared because both appear in recovery and skin research — but their mechanisms are so distinct that they address different biological questions entirely, which is why both appear together in the KLOW Blend rather than being treated as alternatives.

Recovery Research

KPV Complete Research Guide 2026

KPV is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone, studied for targeted NF-κB pathway inhibition — a highly specific anti-inflammatory mechanism that distinguishes it from the broader tissue repair effects of BPC-157 and TB-500.

Recovery Research

GHK-Cu Complete Research Guide 2026

GHK-Cu (copper peptide) is one of the most mechanistically distinct compounds in the research catalog — its activity is inseparable from the copper coordination chemistry that gives it both its research properties and its unusual stability profile compared to standard amino acid peptides.

Recovery Research

BPC-157 vs TB-500 — Which Recovery Peptide to Research in

Researchers comparing BPC-157 and TB-500 often frame it as a choice between two compounds. The more accurate framing is a choice between two mechanisms — and once you understand what each one actually does, the research case for studying both together becomes obvious.

Community
Explore the Community

Neutral, moderated research discussion. Laboratory use only.

Research Library
Read More in the Library

More compound guides, hubs, and educational research materials.